Tyrosine Kinase


Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
A3847 SU54167 CitationTarget: VEGFRSummary: VEGFR2 inhibitor -
A8192 Staurosporine20 CitationSummary: serine/threonine protein kinases inhibitor -
A8329 R42829 CitationSummary: Selective Axl inhibitor -
A1805 Imatinib Mesylate (STI571)2 CitationTarget: PDGFR|c-Kit|Bcr-AblSummary: Abl/c-kit/PDGFR inhibitor -
B1523 PF-5732284 CitationSummary: ATP-competitive FAK inhibitor -
B3686 DMH-12 CitationTarget: BMP and Other Activin ReceptorsSummary: Selective BMP ALK2 receptor -
A3017 Dasatinib (BMS-354825)14 CitationSummary: Src and Bcr-Abl inhibitor -
A3020 (R)-Crizotinib3 CitationTarget: c-METSummary: C-MET/ALK inhibitor,potent and ATP-competitve -
A3022 Pazopanib (GW-786034)Target: CSF-1R|VEGFR|PDGFR|c-Kit|FGFRSummary: VEGFR/PDGFR/FGFR inhibitor -
B2284 Fostamatinib (R788)1 CitationTarget: SykSummary: Spleen tyrosine kinase (Syk) inhibitor

